These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9892595

  • 1. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage.
    Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, Wellens H, de Muinck ED.
    Circulation; 1999 Jan 19; 99(2):276-83. PubMed ID: 9892595
    [Abstract] [Full Text] [Related]

  • 2. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.
    Leppänen P, Luoma JS, Hofker MH, Havekes LM, Ylä-Herttuala S.
    Atherosclerosis; 1998 Jan 19; 136(1):147-52. PubMed ID: 9544741
    [Abstract] [Full Text] [Related]

  • 3. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.
    van Vlijmen BJ, Gerritsen G, Franken AL, Boesten LS, Kockx MM, Gijbels MJ, Vierboom MP, van Eck M, van De Water B, van Berkel TJ, Havekes LM.
    Circ Res; 2001 Apr 27; 88(8):780-6. PubMed ID: 11325869
    [Abstract] [Full Text] [Related]

  • 4. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1994 Apr 27; 93(4):1403-10. PubMed ID: 8163645
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of fibrinogen in ApoE*3-Leiden transgenic mice does not influence the progression of diet-induced atherosclerosis.
    Rezaee F, Gijbels MJ, Offerman EH, van der Linden M, De Maat MP, Verheijen JH.
    Thromb Haemost; 2002 Aug 27; 88(2):329-34. PubMed ID: 12195708
    [Abstract] [Full Text] [Related]

  • 6. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L, Kleemann R, Offerman EH, Szalai AJ, Emeis SJ, Princen HM, Kooistra T.
    Arterioscler Thromb Vasc Biol; 2005 Jan 27; 25(1):161-7. PubMed ID: 15514207
    [Abstract] [Full Text] [Related]

  • 7. Hypercholesterolaemia and circulating levels of CXC chemokines in apoE*3 Leiden mice.
    Murphy N, Grimsditch DC, Parkin S, Vidgeon-Hart MP, Overend P, Groot PH, Graham A, Benson GM.
    Atherosclerosis; 2002 Jul 27; 163(1):69-77. PubMed ID: 12048123
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.
    Boesten LS, Zadelaar AS, van Nieuwkoop A, Gijbels MJ, de Winther MP, Havekes LM, van Vlijmen BJ.
    Cardiovasc Res; 2005 Apr 01; 66(1):179-85. PubMed ID: 15769461
    [Abstract] [Full Text] [Related]

  • 9. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study.
    Gijbels MJ, van der Cammen M, van der Laan LJ, Emeis JJ, Havekes LM, Hofker MH, Kraal G.
    Atherosclerosis; 1999 Mar 01; 143(1):15-25. PubMed ID: 10208477
    [Abstract] [Full Text] [Related]

  • 10. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ, Offerman EH, van Duyvenvoorde W, van Der Boom H, de Wit EC, Gijbels MJ, van Der Laarse A, Jukema JW, Havekes LM, Princen HM.
    Circulation; 2001 Apr 03; 103(13):1778-86. PubMed ID: 11282910
    [Abstract] [Full Text] [Related]

  • 11. Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice.
    Lutgens E, de Muinck ED, Heeneman S, Daemen MJ.
    Arterioscler Thromb Vasc Biol; 2001 Aug 03; 21(8):1359-65. PubMed ID: 11498466
    [Abstract] [Full Text] [Related]

  • 12. Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice.
    Lardenoye JH, de Vries MR, Löwik CW, Xu Q, Dhore CR, Cleutjens JP, van Hinsbergh VW, van Bockel JH, Quax PH.
    Circ Res; 2002 Oct 04; 91(7):577-84. PubMed ID: 12364385
    [Abstract] [Full Text] [Related]

  • 13. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques.
    Lutgens E, de Muinck ED, Kitslaar PJ, Tordoir JH, Wellens HJ, Daemen MJ.
    Cardiovasc Res; 1999 Feb 04; 41(2):473-9. PubMed ID: 10341847
    [Abstract] [Full Text] [Related]

  • 14. Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.
    Murphy N, Bruckdorfer KR, Grimsditch DC, Overend P, Vidgeon-Hart M, Groot PH, Benson GM, Graham A.
    Arterioscler Thromb Vasc Biol; 2003 Sep 01; 23(9):1615-20. PubMed ID: 12842836
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice.
    Lardenoye JH, De Vries MR, Grimbergen JM, Havekes LM, Knaapen MW, Kockx MM, van Hinsbergh VW, van Bockel JH, Quax PH.
    Arterioscler Thromb Vasc Biol; 2002 Sep 01; 22(9):1433-8. PubMed ID: 12231562
    [Abstract] [Full Text] [Related]

  • 16. Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
    Rezaee F, Gijbels M, Offerman E, Verheijen J.
    Thromb Haemost; 2003 Oct 01; 90(4):710-6. PubMed ID: 14515193
    [Abstract] [Full Text] [Related]

  • 17. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
    Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE.
    J Clin Invest; 1995 Nov 01; 96(5):2170-9. PubMed ID: 7593602
    [Abstract] [Full Text] [Related]

  • 18. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content.
    Rong JX, Li J, Reis ED, Choudhury RP, Dansky HM, Elmalem VI, Fallon JT, Breslow JL, Fisher EA.
    Circulation; 2001 Nov 13; 104(20):2447-52. PubMed ID: 11705823
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL, Loeb SM, Weisgraber KH.
    Arterioscler Thromb Vasc Biol; 2005 Feb 13; 25(2):436-41. PubMed ID: 15591220
    [Abstract] [Full Text] [Related]

  • 20. Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice.
    van De Poll SW, Römer TJ, Volger OL, Delsing DJ, Bakker Schut TC, Princen HM, Havekes LM, Jukema JW, van Der Laarse A, Puppels GJ.
    Arterioscler Thromb Vasc Biol; 2001 Oct 13; 21(10):1630-5. PubMed ID: 11597937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.